US Patent 12018059 Human amylin analog polypeptides and methods of use
Patent 12018059 was granted and assigned to i2O Therapeutics, Inc. on June, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 12018059 Human amylin analog polypeptides and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
